# A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.

> **NCT05554237** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** PF-07612577
- **DRUG:** PF-06264006

## Key facts

- **NCT ID:** NCT05554237
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-07
- **Primary completion:** 2023-06-23
- **Final completion:** 2023-06-23
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05554237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05554237, "A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05554237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*